Area of research
Epidemiology · Physiology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Adipose Tissue and Metabolism, Gut microbiota and health, and Lipid metabolism and biosynthesis.
Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans
The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non‐alcoholic fatty liver disease
Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancy
Overeating Saturated Fat Promotes Fatty Liver and Ceramides Compared With Polyunsaturated Fat: A Randomized Trial
Pyruvate kinase L/R is a regulator of lipid metabolism and mitochondrial function
Obeticholic acid may increase the risk of gallstone formation in susceptible patients
Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1
Vimentin deficiency in macrophages induces increased oxidative stress and vascular inflammation but attenuates atherosclerosis in mice
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
Bifidobacteria or Fiber Protects against Diet-Induced Microbiota-Mediated Colonic Mucus Deterioration
Network analyses identify liver‐specific targets for treating liver diseases
Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism
Sphingolipids Contribute to Human Atherosclerotic Plaque Inflammation
Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation
Increased Expression of the Very Low-Density Lipoprotein Receptor Mediates Lipid Accumulation in Clear-Cell Renal Cell Carcinoma
Clinical dyslipidaemia is associated with changes in the lipid composition and inflammatory properties of apolipoprotein-B-containing lipoproteins from women with type 2 diabetes